BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yamao T, Imai K, Yamashita YI, Kaida T, Nakagawa S, Mima K, Hashimoto D, Chikamoto A, Ishiko T, Baba H. Surgical treatment strategy for hepatocellular carcinoma in patients with impaired liver function: hepatic resection or radiofrequency ablation? HPB (Oxford) 2018;20:244-50. [PMID: 28988913 DOI: 10.1016/j.hpb.2017.08.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sadikbasha S, Deoghare AB. In-silico Analysis of Expandable Radiofrequency Electrode for Ablation of Hepatic Tumors. MEMS and Microfluidics in Healthcare 2023. [DOI: 10.1007/978-981-19-8714-4_7] [Reference Citation Analysis]
2 Liu R, Liu Q. Decision Making Process for Interveners. Clinical Decision Making for Improving Prognosis 2022. [DOI: 10.1007/978-981-19-2952-6_3] [Reference Citation Analysis]
3 Saito R, Amemiya H, Hosomura N, Kawaida H, Maruyama S, Shimizu H, Furuya S, Akaike H, Kawaguchi Y, Sudo M, Inoue S, Kono H, Ichikawa D. Prognostic Significance of Treatment Strategies for the Recurrent Hepatocellular Carcinomas After Radical Resection. In Vivo 2020;34:1265-70. [PMID: 32354917 DOI: 10.21873/invivo.11900] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nakagawa S, Yamashita YI, Umezaki N, Yamao T, Kaida T, Hiyoshi Y, Mima K, Okabe H, Hayashi H, Imai K, Chikamoto A, Baba H. Four gene intrahepatic metastasis-risk signature predicts hepatocellular carcinoma malignant potential and early recurrence from intrahepatic metastasis. Surgery 2021;169:903-10. [PMID: 33160638 DOI: 10.1016/j.surg.2020.09.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Imai K, Yamashita YI, Nakao Y, Matsumoto T, Kinoshita S, Yusa T, Kitano Y, Kaida T, Hayashi H, Baba H. Is Portal Vein Embolization Followed by Hepatectomy for Hepatocellular Carcinoma Justified in Patients with Impaired Liver Function? Ann Surg Oncol 2021;28:854-62. [PMID: 32740735 DOI: 10.1245/s10434-020-08960-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tsukamoto M, Imai K, Yamashita YI, Kitano Y, Okabe H, Nakagawa S, Nitta H, Chikamoto A, Ishiko T, Baba H. Endoscopic hepatic resection and endoscopic radiofrequency ablation as initial treatments for hepatocellular carcinoma within the Milan criteria. Surg Today 2020;50:402-12. [PMID: 31680205 DOI: 10.1007/s00595-019-01903-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Lemdani K, Salmon H, Gahoual R, Bessodes M, Scherman D, Houzé P, Seguin J, Mignet N. Assessment of the targeting specificity of a fluorescent albumin conceived as a preclinical agent of the liver function. Nanoscale 2018;10:21151-60. [DOI: 10.1039/c8nr04163f] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]